Trial Profile
A study of the safety of alpha1-blocker silodosin in adult women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2014
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Adverse reactions
- 19 Jun 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 26 Oct 2012 New trial record